Veradermics' oral hair loss drug shows strong regrowth in late-stage trial
Veradermics announced that its oral hair-loss medicine VDPHL01 significantly boosted hair growth in a six-month late-stage trial, with men on the drug gaining 30–33 more hairs per cm² versus about 7 in the placebo; 79–86% of participants and 72–84% of investigators reported improvement, signaling promising efficacy for the therapy.